GDF15 and COVID-19: Based in all the above, the aims of this study were: i) to analyze whether GDF15 and ACE2 levels correlate with a worse COVID-19 prognosis as well as with other inflammatory and cellular markers of damage and senescence, and ii) to determine if different SNPs variants within ACE2 were associated to disease severity.